Financial disclosure records released by the US Office of Government Ethics during the week of May 15, 2026, confirmed that President Donald Trump purchased between $247,008 and $630,000 worth of Palantir Technologies Inc. (NASDAQ: PLTR) shares during the first quarter of 2026, including at least seven separate transactions in March alone totalling as much as $530,000.
Weeks after those purchases, on April 10, Trump posted on his Truth Social platform praising Palantir directly by name and ticker, writing that the company had “proven to have great war fighting capabilities and equipment.”
The sequence of events, buy first, publish praise second, has drawn significant scrutiny, though the White House has offered a standard and legally relevant defence: Trump’s investments are managed through discretionary accounts overseen by independent financial institutions, meaning Trump and his family do not directly control specific trades.
That explanation matters legally because it creates a structural argument against any claim of intentional market manipulation, since a discretionary manager, not the president, would have initiated the purchases.
Importantly, the OGE records also reveal that Trump sold as much as $5 million worth of Palantir shares on February 10, a transaction that predated the later March buying, and made several other Palantir sales over approximately two weeks, suggesting the March purchases represented a re-entry into the position rather than a straightforward accumulation trade followed by a promotional post.
The April 10 Truth Social post came during a period when Palantir shares had suffered their worst week in more than a year, driven by broader market volatility tied to the Iran war and concerns about competitive pressure in the enterprise AI market, with Michael Burry having publicly stated his view that PLTR was approximately 66% overvalued at current levels.
Following the Truth Social post, the stock reversed meaningfully, recovering from approximately $128.06 to $152.62 by April 22, a sequence that is now being scrutinised both by ethics watchdogs and by ordinary investors who are asking whether the presidential post constituted material market-moving commentary.
The Palantir trades are one thread in a far larger disclosure picture: Trump executed approximately 3,700 individual stock transactions between January and March 2026, totalling somewhere between $220 million and $750 million based on the OGE’s range-based reporting format.
Other notable Q1 positions include purchases of more than $1 million each in Nvidia (NASDAQ: NVDA), Apple (NASDAQ: AAPL), Amazon (NASDAQ: AMZN), Microsoft (NASDAQ: MSFT), and Oracle (NYSE: ORCL), alongside buys in Broadcom (NASDAQ: AVGO) and ServiceNow (NYSE: NOW) during the software sector’s early-year selloff.
The volume of activity alone raises governance questions that go beyond any single stock, as a president executing thousands of equity trades quarterly while simultaneously setting industrial policy, tariff schedules, government contracts, and military strategy creates a structural conflict of interest that the discretionary account defence does not fully address.
Palantir has deep institutional ties to the Trump administration, with the company’s software being used across defence and intelligence agencies, CEO Alex Karp having close relationships with administration officials, and Palantir having sponsored Trump’s military parade held in June 2025 for the US Army’s 250th anniversary.
The company reported Q1 2026 revenue of $1.63 billion, beating analyst expectations of $1.54 billion, representing 84.7% year-on-year growth, with net margins of 43.67%.
Whether the trades represent a legal, ethical, or purely optics problem depends on how the discretionary account structure holds up to scrutiny and whether any evidence emerges of communication between the president or his staff and the independent financial managers handling the portfolio during the relevant periods, a question that the OGE records alone cannot answer.
